NuGen Medical Devices Inc (79O) Stock Statistics & Valuation Metrics
Total Valuation
NuGen Medical Devices Inc has a market cap or net worth of EUR 2.15M. The enterprise value is EUR 22.46M.
- Market Cap
- EUR 2.15M
- Enterprise Value
- EUR 22.46M
Share Statistics
NuGen Medical Devices Inc has 227,035,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 227,035,680
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
NuGen Medical Devices Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -244.69K
- Employee Count
- 15
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, NuGen Medical Devices Inc had revenue of ― and earned -3.67M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 34.38K
- Operating Income
- -2.61M
- Pretax Income
- ―
- Net Income
- -3.67M
- EBITDA
- -2.59M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 1.76
- 52-Week Price Change
- -62.96%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 42.14
- Average Volume (3m)
- 75.00K
Important Dates
NuGen Medical Devices Inc upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Dec 02, 2026
- Ex-Dividend Date
- ―
Balance Sheet
NuGen Medical Devices Inc has ― in cash and marketable securities with EUR 7.49M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- EUR 7.49M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for NuGen Medical Devices Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -87.31%
- EPS Growth Forecast
- -177.89%

